The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Seagen
Stock and Other Ownership Interests - Seagen

Implementation strategies for monitoring adherence in real time (iSMART): A pilot randomized trial.
 
Katharine A. Rendle
Honoraria - MJH Healthcare Holdings, LLC
Consulting or Advisory Role - Merck
Research Funding - AstraZeneca; Pfizer (Inst)
Travel, Accommodations, Expenses - MJH Healthcare Holdings, LLC
 
Jocelyn Wainwright
No Relationships to Disclose
 
Donna Pucci
No Relationships to Disclose
 
Deirdre Yarosh
No Relationships to Disclose
 
Christine Cambareri
No Relationships to Disclose
 
Linda A. Jacobs
No Relationships to Disclose
 
Abigail Blauch
No Relationships to Disclose
 
Abigail Mandel
Employment - Memora Health
Stock and Other Ownership Interests - Memora Health
 
Caleb Johnston
No Relationships to Disclose
 
James Colbert
Employment - Memora Health
Leadership - Memora Health
Travel, Accommodations, Expenses - Memora Health
 
Bethany Mooney
No Relationships to Disclose
 
Justin E. Bekelman
Stock and Other Ownership Interests - Reimagine Care
Honoraria - National Comprehensive Cancer Network
Consulting or Advisory Role - Reimagine Care; UnitedHealthcare
Research Funding - Loxo@Lilly (Inst)
 
Stephen E. Kimmel
Research Funding - Pfizer
Expert Testimony - GlaxoSmithKline
 
Roy Rosin
Consulting or Advisory Role - Sage Therapeutics
 
Lawrence N. Shulman
Consulting or Advisory Role - Genentech
Research Funding - Celgene (Inst); Independence Blue Cross (Inst)
 
E. Paul Wileyto
No Relationships to Disclose
 
Sarah Cohen
No Relationships to Disclose
 
Charu Aggarwal
Consulting or Advisory Role - AstraZeneca; BeiGene; Blueprint Genetics; Boehringer Ingelheim; Celgene; Daiichi Sankyo/Astra Zeneca; Eisai; Genentech; Janssen; Lilly; Merck; Pfizer; Sanofi/Regeneron; Shionogi; Turning Point Therapeutics
Speakers' Bureau - AstraZeneca (I); Roche/Genentech (I)
Research Funding - AstraZeneca/MedImmune (Inst); Genentech/Roche (Inst); Incyte (Inst); Macrogenics (Inst); Merck Sharp & Dohme (Inst)
 
Corey J. Langer
Honoraria - AstraZeneca; Genentech/Roche; Lilly/ImClone; Merck; Takeda Science Foundation
Consulting or Advisory Role - Abbott Biotherapeutics; ARIAD; AstraZeneca; Bayer/Onyx; Bristol-Myers Squibb; Cancer Support Community; Celgene; Clarient; Clovis Oncology; Genentech/Roche; Gilead Sciences; Lilly/ImClone; Merck; Novocure; Pfizer; Regeneron; Takeda
Research Funding - Advantagene (Inst); Amgen; Ariad (Inst); AstraZeneca; Celgene (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Incyte; Inovio Pharmaceuticals (Inst); Johnson & Johnson/Janssen; Lilly; Merck (Inst); Stem CentRx (Inst); Trizell (Inst)
Other Relationship - Amgen; Lilly; OncoCyte; Peregrine Pharmaceuticals; Synta
 
Samuel U Takvorian
Stock and Other Ownership Interests - Bluebird Bio (I); Gilead Sciences (I); Johnson & Johnson (I); Merck (I); Novartis (I); Pfizer (I); Pfizer (I); Portola Pharmaceuticals (I)
Consulting or Advisory Role - AstraZeneca/Merck; Boehringer Ingelheim (I); Genentech; Health Advances; Novartis (I); Novocure (I)
Research Funding - AstraZeneca (I); Lilly (I); Pfizer; Trizell (I)